In this study, we conducted a comprehensive analysis of the process of cardiac hypertrophy, including mild, moderate hypertrophy, and aggravated heart failure, to further illustrate the alterations in MAM-related proteins during these phases. Here, SGCG is linked to cardiac hypertrophy.